Contract research
It is a long path from the development of an active pharmaceutical ingredient in the lab to an effective drug – a process that takes several years. Campus companies are often involved in this process on behalf of the pharmaceutical and biotech industry or academic groups.
The company Experimental Pharmacology & Oncology Berlin-Buch (EPO) is a leader in preclinical cancer research in Germany. Worldwide, EPO offers customized and comprehensive service for the preclinical development of novel cancer drugs and is specialized in the development of individualized tumor models.
News innovation
Talk im Cube: Financing Models for Biotechs
We are excited to invite to a further engaging panel discussion focused on the critical topic of financing models in biotechnology companies. Join us as we explore the various funding strategies that ...
more ...Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today a...
more ...Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenbu...
more ...Events Campus
22.11.2024, 19:00
Der Jeanne Mammen Salon „Aufbruch“
Anlässlich des 134. Geburtstags der Berliner Künstlerin lassen wir am 22. November 2024 ab 19:00 Uhr im Jeanne Mammen Saal im Torhaus des Campus Berlin-Buch die Tradition der Berliner Salonabende wied...
more ...26.11.2024, 18:00
Campuskino: "Séraphine", ein Film von Martin Provost (Frankreich 2008)
Der Freundeskreis des Max Delbrück Center lädt ein zum Campuskino
more ...28.11.2024, 17:00
Talk im Cube: Financing Models for Biotechs
We are excited to invite to a further engaging panel discussion focused on the critical topic of financing models in biotechnology companies. Join us as we explore the various funding strategies that ...
more ...
